TOR1AIP1 anticorps (C-Term)

N° du produit ABIN5517479

Détail du produit anti-TOR1AIP1 anticorps

Antigène: TOR1AIP1 (Torsin A Interacting Protein 1 (TOR1AIP1))

Épitope: C-Term

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp TOR1AIP1 est non-conjugé

Application: Western Blotting (WB)

Séquence: VALVLTVLLE EETLGTSLGL KEVEEKVRDF LKVKFTNSNT PNSYNHMDPD

Purification: Affinity purified

Immunogène: The immunogen is a synthetic peptide directed towards the C terminal region of human TOR1AIP1

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.

Détails sur TOR1AIP1

Antigène: TOR1AIP1 (Torsin A Interacting Protein 1 (TOR1AIP1))

Autre désignation: TOR1AIP1 (TOR1AIP1 Produits)

Synonymes: anticorps LAP1, anticorps LAP1B, anticorps Lap1B, anticorps Lap1b, anticorps Lap1c, anticorps torsin 1A interacting protein 1, anticorps torsin A interacting protein 1, anticorps TOR1AIP1, anticorps Tor1aip1

Sujet: This gene encodes a type 2 integral membrane protein that binds A- and B-type laminins. The encoded protein localizes to the inner nuclear membrane and may be involved in maintaining the attachment of the nuclear membrane to the nuclear lamina during cell division. Alternate splicing results in multiple transcript variants.

Alias Symbols: LAP1, LAP1B

Protein Size: 167

ID gène: 26092

NCBI Accession: NM_001267578, NP_001254507

UniProt: Q5JTV8

Pathways: SARS-CoV-2 Protein Interactome, Phosphorylation & l'infection par le SRAS-CoV-2